Clinical development of medicinal products for the treatment of allergic rhino-conjunctivitis - Scientific guideline

This document addresses issues of study design, efficacy and safety for new medicinal products intended for the symptomatic treatment and overall pharmacological management of allergic rhino-conjunctivitis.

Keywords: Allergen, seasonal and perennial allergic rhino-conjunctivitis

Current effective version

Guideline on the clinical development of medicinal products for the treatment of allergic rhino-conjunctivitis

AdoptedReference Number: CHMP/EWP/2455/02Legal effective date: 01/05/2005